Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yun-Jing Zhang, Wen-Li Zhou, Fei Yu, Qian Wang, Can Peng & Jia-Yi Kan. (2021) Evaluation of the effect of Bovis Calculus Artifactus on eight rat liver cytochrome P450 isozymes using LC-MS/MS and cocktail approach. Xenobiotica 51:9, pages 1010-1018.
Read now
Read now
Yoshiya Yamamura, Noriyuki Koyama & Ken Umehara. (2015) Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies. Xenobiotica 45:4, pages 353-360.
Read now
Read now
David J Greenblatt & Gary K Zammit. (2012) Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1609-1618.
Read now
Read now
James J Cali, Dongping Ma, Mary Sobol, Daniel J Simpson, Susan Frackman, Troy D Good, William J Daily & David Liu. (2006) Luminogenic cytochrome P450 assays. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 629-645.
Read now
Read now
Manoj Bajpai & Joel D. Esmay. (2002) IN VITRO STUDIES IN DRUG DISCOVERY AND DEVELOPMENT: AN ANALYSIS OF STUDY OBJECTIVES AND APPLICATION OF GOOD LABORATORY PRACTICES (GLP). Drug Metabolism Reviews 34:4, pages 679-689.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
S. A. Roberts. (2001) High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. Xenobiotica 31:8-9, pages 557-589.
Read now
Read now
Articles from other publishers (51)
Stefano Fontana, Simone Braggio, Mauro Corsi, Rob Riley, Chris Strock, Jenifer Bradley, Caterina Virginio & Paul Walker. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
533
596
.
Mengjun Shi, Yiping Cui, Cunyu Liu, Changqin Li, Zhenhua Liu & Wen-yi Kang. (2020) CYPs-mediated drug-drug interactions on psoralidin, isobavachalcone, neobavaisoflavone and daidzein in rats liver microsomes. Food and Chemical Toxicology 136, pages 111027.
Crossref
Crossref
J. Murray, D. Picking, A. Lamm, J. McKenzie, S. Hartley, C. Watson, L. Williams, H. Lowe & R. Delgoda. (2016) Significant inhibitory impact of dibenzyl trisulfide and extracts of Petiveria alliacea on the activities of major drug-metabolizing enzymes in vitro: An assessment of the potential for medicinal plant-drug interactions. Fitoterapia 111, pages 138-146.
Crossref
Crossref
Li Di & Edward H. Kerns. 2016. Drug-Like Properties. Drug-Like Properties
401
414
.
Valerie M. Kramlinger, Mónica Alvarado Rojas, Tatsuyuki Kanamori & F. Peter Guengerich. (2015) Cytochrome P450 3A Enzymes Catalyze the O6-Demethylation of Thebaine, a Key Step in Endogenous Mammalian Morphine Biosynthesis. Journal of Biological Chemistry 290:33, pages 20200-20210.
Crossref
Crossref
Li‐Ya Liu, Yong‐Long Han, Jin‐Hui Zhu, Qi Yu, Quan‐Jun Yang, Jin Lu & Cheng Guo. (2014)
A sensitive and high‐throughput LC‐MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an
in vitro
cocktail of probe substrates
. Biomedical Chromatography 29:3, pages 437-444.
Crossref
Crossref
Qian Zhao, Yan Li, Jinping Hu, Xin Zheng, Ji Jiang & Pei Hu. (2014) LC?MS?MS Method to Simultaneously Determine Six Probe Drugs for CYP450 Isozymes in Human Liver Microsomes. Chromatographia 77:13-14, pages 913-922.
Crossref
Crossref
Jared M. MudrikMichael D.M. DrydenNelson M. LafrenièreAaron R. Wheeler. (2014) Strong and small: strong cation-exchange solid-phase extractions using porous polymer monoliths on a digital microfluidic platform. Canadian Journal of Chemistry 92:3, pages 179-185.
Crossref
Crossref
Chong‐Zhen Qin, Xian Ren, Zhi‐Rong Tan, Yao Chen, Ji‐Ye Yin, Jing Yu, Jian Qu, Hong‐Hao Zhou & Zhao‐Qian Liu. (2013)
A high‐throughput inhibition screening of major human cytochrome P450 enzymes using an
in vitro
cocktail and liquid chromatography–tandem mass spectrometry
. Biomedical Chromatography 28:2, pages 197-203.
Crossref
Crossref
Virginie Y. Martiny & Maria A. Miteva. (2013) Advances in Molecular Modeling of Human Cytochrome P450 Polymorphism. Journal of Molecular Biology 425:21, pages 3978-3992.
Crossref
Crossref
Dipti B Ruikar & Sadhana J Rajput. (2012) Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design. DARU Journal of Pharmaceutical Sciences 20:1.
Crossref
Crossref
Alexander V. LyubimovHiroshi Komura & Masahiro Iwaki. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
41
.
Utkarsh Doshi & Albert P. Li. (2011) Luciferin IPA–Based Higher Throughput Human Hepatocyte Screening Assays for CYP3A4 Inhibition and Induction. SLAS Discovery 16:8, pages 903-909.
Crossref
Crossref
Siamak Cyrus Khojasteh, Saileta Prabhu, Jane R. Kenny, Jason S. Halladay & Anthony Y. H. Lu. (2011) Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. European Journal of Drug Metabolism and Pharmacokinetics 36:1, pages 1-16.
Crossref
Crossref
Maryam Modarai, Andy Suter, Andreas Kortenkamp & Michael Heinrich. (2011)
The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (
Harpagophyti radix
) preparations
. Journal of Pharmacy and Pharmacology 63:3, pages 429-438.
Crossref
Crossref
Ragu Ramanathan, S Çömezoglu & W Humphreys. 2009. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition
127
203
.
Albert P. Li. (2009) Evaluation of Luciferin-Isopropyl Acetal as a CYP3A4 Substrate for Human Hepatocytes: Effects of Organic Solvents, Cytochrome P450 (P450) Inhibitors, and P450 Inducers. Drug Metabolism and Disposition 37:8, pages 1598-1603.
Crossref
Crossref
Li Zhang, Min-ji Wei, Cai-yun Zhao & Hui-min Qi. (2008) Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes. Acta Pharmacologica Sinica 29:12, pages 1507-1514.
Crossref
Crossref
Edward H. Kerns & Li Di. 2008. Drug-like Properties: Concepts, Structure Design and Methods. Drug-like Properties: Concepts, Structure Design and Methods
360
371
.
Tong Lin, Kristine Pan, Joyce Mordenti & Lin Pan. (2007) In vitro assessment of cytochrome P450 inhibition: Strategies for increasing LC/MS‐based assay throughput using a one‐point IC50 method and multiplexing high‐performance liquid chromatography. Journal of Pharmaceutical Sciences 96:9, pages 2485-2493.
Crossref
Crossref
Ming Yao, Mingshe Zhu, Michael W. Sinz, Hongjian Zhang, W. Griffith Humphreys, A. David Rodrigues & Renke Dai. (2007) Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC–MS/MS analysis. Journal of Pharmaceutical and Biomedical Analysis 44:1, pages 211-223.
Crossref
Crossref
Danielle Smith, Nalini Sadagopan, Michael Zientek, Anita Reddy & Lucinda Cohen. (2007) Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery. Journal of Chromatography B 850:1-2, pages 455-463.
Crossref
Crossref
Fan He, Hui‐chang Bi, Zhi‐yong Xie, Zhong Zuo, Jian‐kang Li, Xin Li, Li‐zi Zhao, Xiao Chen & Min Huang. (2007) Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high‐throughput inhibition screening of terpenoids. Rapid Communications in Mass Spectrometry 21:5, pages 635-643.
Crossref
Crossref
Anthony Atkinson, Jane R. Kenny & Ken Grime. (2005) AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS. Drug Metabolism and Disposition 33:11, pages 1637-1647.
Crossref
Crossref
Min‐Jung Kim, Hyojin Kim, In‐June Cha, Jang‐Su Park, Ji‐Hong Shon, Kwang‐Hyeon Liu & Jae‐Gook Shin. (2005)
High‐throughput screening of inhibitory potential of nine cytochrome P450 enzymes
in vitro
using liquid chromatography/tandem mass spectrometry
. Rapid Communications in Mass Spectrometry 19:18, pages 2651-2658.
Crossref
Crossref
S. Bhoopathy, B. Xin, S.E. Unger & H.T. Karnes. (2005) A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes. Journal of Pharmaceutical and Biomedical Analysis 37:4, pages 739-749.
Crossref
Crossref
Anima Ghosal, Ragulan Ramanathan, Narendra S. Kishnani, Swapan K. Chowdhury & Kevin B. Alton. 2005. Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes by LC-MS. Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes by LC-MS
295
336
.
Robert L. Walsky & R. Scott Obach. (2004) VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES. Drug Metabolism and Disposition 32:6, pages 647-660.
Crossref
Crossref
Fabian Kuhn, Michael Oehme & Michael Schleimer. (2003) Performance and reliability of splitless microliter gradient pumps in a metabolic stability study using cytochrome P450/3A4 and capillary liquid chromatography–mass spectrometry. Journal of Chromatography A 1018:2, pages 203-212.
Crossref
Crossref
Richard Weaver, Ken S. Graham, Iain G. Beattie & Rob J. Riley. (2003) CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION. Drug Metabolism and Disposition 31:7, pages 955-966.
Crossref
Crossref
Chongwoo Yu, Young Geun Shin, Jerome W. Kosmeder, John M. Pezzuto & Richard B. van Breemen. (2003) Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol‐3‐sulfate. Rapid Communications in Mass Spectrometry 17:4, pages 307-313.
Crossref
Crossref
Jagdish K. Racha, Z. Sylvia Zhao, Nicholas Olejnik, Nadine Warner, Rebecca Chan, David Moore & Hiroko Satoh. (2003) Substrate Dependent Inhibition Profiles of Fourteen Drugs on CYP3A4 Activity Measured by A High Throughput LCMS/MS Method with Four Probe Drugs, Midazolam, Testosterone, Nifedipine and Terfenadine. Drug Metabolism and Pharmacokinetics 18:2, pages 128-138.
Crossref
Crossref
. 2003. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies
361
432
.
. 2003. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies
135
197
.
. 2003. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies
41
74
.
Samuel A TestinoJr.Jr. & Gabor Patonay. (2003) High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 30:5, pages 1459-1467.
Crossref
Crossref
Tianyi Zhang, Yongxin Zhu & Chandrani Gunaratna. (2002) Rapid and quantitative determination of metabolites from multiple cytochrome P450 probe substrates by gradient liquid chromatography–electrospray ionization-ion trap mass spectrometry. Journal of Chromatography B 780:2, pages 371-379.
Crossref
Crossref
E.S.M Lutz, M.E Markling & C.M Masimirembwa. (2002) Monolithic silica rod liquid chromatography with ultraviolet or fluorescence detection for metabolite analysis of cytochrome P450 marker reactions. Journal of Chromatography B 780:2, pages 205-215.
Crossref
Crossref
S Bhoopathy, M.A Sarkar & H.T Karnes. (2002) Characterization of quinidine 3-hydroxylation as a probe for the CYP 3A enzyme using a novel capillary electrophoresis technique. European Journal of Pharmaceutical Sciences 16:4-5, pages 265-272.
Crossref
Crossref
Cornelis E. C. A. Hop, Phillip R. Tiller & Leslie Romanyshyn. (2002) In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry. Rapid Communications in Mass Spectrometry 16:3, pages 212-219.
Crossref
Crossref
Richard C. King, Cynthia Miller‐Stein, Daniel J. Magiera & John Brann. (2001) Description and validation of a staggered parallel high performance liquid chromatography system for good laboratory practice level quantitative analysis by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 16:1, pages 43-52.
Crossref
Crossref
Takahito Yamamoto, Akio Suzuki & Yoshiro Kohno. (2002) Application of Microtiter Plate Assay to Evaluate Inhibitory Effects of Various Compounds on Nine Cytochrome P450 Isoforms and to Estimate their Inhibition Patterns. Drug Metabolism and Pharmacokinetics 17:5, pages 437-448.
Crossref
Crossref
Hai-Zhi Bu, Kim Knuth, Lisa Magis & Philip Teitelbaum. (2001) High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction−tandem mass spectrometry method for CYP2C19 inhibition evaluation. Journal of Pharmaceutical and Biomedical Analysis 25:3-4, pages 437-442.
Crossref
Crossref
Hai‐Zhi Bu, Lisa Magis, Kim Knuth & Philip Teitelbaum. (2001) High‐throughput cytochrome P450 (CYP) inhibition screening via a cassette probe‐dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1. Rapid Communications in Mass Spectrometry 15:10, pages 741-748.
Crossref
Crossref
Ilona Kariv, Mark P. Fereshteh & Kevin R. Oldenburg. (2001) Development of a Miniaturized 384-Well High Throughput Screen for the Detection of Substrates of Cytochrome P450 2D6 and 3A4 Metabolism. SLAS Discovery 6:2, pages 91-99.
Crossref
Crossref
Hai-Zhi Bu, Lisa Magis, Kim Knuth & Philip Teitelbaum. (2001) High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. Journal of Chromatography B: Biomedical Sciences and Applications 753:2, pages 321-326.
Crossref
Crossref
Hai-Zhi Bu, Kim Knuth, Lisa Magis & Philip Teitelbaum. (2001) High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. European Journal of Pharmaceutical Sciences 12:4, pages 447-452.
Crossref
Crossref
Sheila J. Sadeghi, Georgia E. Tsotsou, Michael Fairhead, Yergalem T. Meharenna & Gianfranco Gilardi. 2000. Physics and Chemistry Basis of Biotechnology. Physics and Chemistry Basis of Biotechnology
71
104
.
L. Ramos, N. Brignol, R. Bakhtiar, T. Ray, L. M. Mc Mahon & F. L. S. Tse. (2000) High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma. Rapid Communications in Mass Spectrometry 14:23, pages 2282-2293.
Crossref
Crossref
Hai-Zhi Bu, Kim Knuth, Lisa Magis & Philip Teitelbaum. (2000) High-throughput cytochrome P450 inhibition screening via cassette probe-dosing strategy. IV. Validation of a direct injection on-line guard cartridge extraction/tandem mass spectrometry method for simultaneous CYP3A4, 2D6 and 2E1 inhibition assessment. Rapid Communications in Mass Spectrometry 14:20, pages 1943-1948.
Crossref
Crossref
Sean Ekins, Barbara J. Ring, James Grace, Donna J. McRobie-Belle & Steven A. Wrighton. (2000) Present and future in vitro approaches for drug metabolism. Journal of Pharmacological and Toxicological Methods 44:1, pages 313-324.
Crossref
Crossref